Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
EVHC
Envision Healthcare Holdings Inc
EVHC
|
+$319M |
| 2 |
GSK
GSK
|
+$230M |
| 3 |
LO
LORILLARD INC COM STK
LO
|
+$192M |
| 4 |
Verizon
VZ
|
+$174M |
| 5 |
Mastercard
MA
|
+$160M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$5.08B |
| 2 |
INP
iPath ETNs Linked to the MSCI India Total Return Index
INP
|
+$850M |
| 3 |
VXX
iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019
VXX
|
+$781M |
| 4 |
Bausch Health
BHC
|
+$466M |
| 5 |
Meta Platforms (Facebook)
META
|
+$407M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 7.58% |
| 2 | Technology | 5.48% |
| 3 | Financials | 4.9% |
| 4 | Energy | 3.61% |
| 5 | Consumer Discretionary | 3.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SGI
5776
DELISTED
Silicon Graphics Intl.
SGI
| $17K | ﹤0.01% |
2,114
-13,154
| -86% | -$130K |
|
|
DTSI
5777
DELISTED
DTS, Inc.
DTSI
| $17K | ﹤0.01% |
507
-459
| -48% | -$14.1K |
|
|
NWLIA
5778
DELISTED
NATL WESTN LIFE INS CO CL A
NWLIA
| $17K | ﹤0.01% |
68
-59
| -46% | -$14.8K |
|
5779
Compugen
CGEN
$228M
| $16K | ﹤0.01% |
2,316
+2,116
| +1,058% | +$17.3K |
|
5780
Columbus McKinnon
CMCO
$584M
| $16K | ﹤0.01% |
594
-536
| -47% | -$13.8K |
|
5781
Coca-Cola Consolidated
COKE
$12.8B
| $16K | ﹤0.01% |
1,400
-1,250
| -47% | -$12.7K |
|
5782
CareTrust REIT
CTRE
$9.74B
| $16K | ﹤0.01% |
1,237
+99
| +9% | +$1.28K |
|
5783
ProShares UltraShort Euro
EUO
$34.6M
| $16K | ﹤0.01% |
+632
| New | +$15.7K |
|
5784
PUT
Flex
FLEX
$44.8B
| $16K | ﹤0.01% |
1,725
-7,697
| -82% | -$67.5K |
|
5785
Gorman-Rupp
GRC
$2.21B
| $16K | ﹤0.01% |
561
-970
| -63% | -$28.5K |
|
5786
Heritage Financial
HFWA
$1.21B
| $16K | ﹤0.01% |
901
-3,219
| -78% | -$52.6K |
|
5787
HealthStream
HSTM
$839M
| $16K | ﹤0.01% |
636
-569
| -47% | -$15.5K |
|
5788
Interparfums
IPAR
$3.94B
| $16K | ﹤0.01% |
502
-849
| -63% | -$23.7K |
|
5789
Kforce
KFRC
$1.06B
| $16K | ﹤0.01% |
748
-1,267
| -63% | -$29.4K |
|
5790
Stride
LRN
$3.43B
| $16K | ﹤0.01% |
1,030
-1,494
| -59% | -$22.2K |
|
5791
Phibro Animal Health
PAHC
$1.39B
| $16K | ﹤0.01% |
442
-392
| -47% | -$12.6K |
|
5792
PDF Solutions
PDFS
$2.07B
| $16K | ﹤0.01% |
916
-1,563
| -63% | -$27.2K |
|
|
RGLS
5793
DELISTED
Regulus Therapeutics
RGLS
| $16K | ﹤0.01% |
9
-17
| -65% | -$36.9K |
|
5794
TriNet
TNET
$3.14B
| $16K | ﹤0.01% |
471
-12,905
| -96% | -$444K |
|
5795
CALL
Upbound Group
UPBD
$1.16B
| $16K | ﹤0.01% |
600
-1,300
| -68% | -$39.6K |
|
5796
CALL
Marriott Vacations Worldwide
VAC
$4.24B
| $16K | ﹤0.01% |
+200
| New | +$15.5K |
|
5797
Weis Markets
WMK
$1.86B
| $16K | ﹤0.01% |
330
-565
| -63% | -$27.3K |
|
5798
Waterstone Financial
WSBF
$375M
| $16K | ﹤0.01% |
1,330
-1,568
| -54% | -$20.2K |
|
5799
PUT
Zumiez
ZUMZ
$339M
| $16K | ﹤0.01% |
400
-100
| -20% | -$3.88K |
|
|
ATRI
5800
DELISTED
Atrion Corp
ATRI
| $16K | ﹤0.01% |
45
-43
| -49% | -$14.3K |
|
Similar funds
Barclays's Q1 2015 Portfolio in Review
As of Q1 2015, Barclays held 7,637 positions worth $86.7B, down 17% from $104B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Barclays withdrew a net $19.4B in Q1 2015, closing 488 positions and reducing 4,377 holdings. Its most notable exit was iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019, an estimated $781M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 7.6% of assets, up from 5.7% a quarter earlier, followed by Technology and Financials.
Against the trend, Barclays opened a new position in iPath Pure Beta Broad Commodity ETN worth $55.8M.
- Barclays's largest Q1 2015 buy was iPath Pure Beta Broad Commodity ETN: 1,861,500 shares worth $55.8M.
- Barclays added most to Envision Healthcare Holdings Inc in Q1 2015, an estimated $319M increase.
- Barclays's biggest Q1 2015 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $5.08B.
- Barclays fully exited iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019 in Q1 2015, selling an estimated $781M.
- Barclays's ten largest holdings make up 25% of its $86.7B portfolio in Q1 2015.
- Barclays opened 330 new positions and closed 488 in Q1 2015.
- Barclays's portfolio value fell 17% quarter-over-quarter to $86.7B.
Based on Barclays's 13F filing for Q1 2015, filed 14 May 2015.